Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCAN
Shaoming Wang(Shihezi University), Jie He(Chinese Academy of Medical Sciences & Peking Union Medical College), Kexin Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Freddie Bray(Centre International de Recherche sur le Cancer), Rongshou Zheng(Chinese Academy of Medical Sciences & Peking Union Medical College), Bingfeng Han(Chinese Academy of Medical Sciences & Peking Union Medical College), Li Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Ru Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Hongmei Zeng(Chinese Academy of Medical Sciences & Peking Union Medical College), Jiayue Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Wenqiang Wei(Chinese Academy of Medical Sciences & Peking Union Medical College)
Cited by 248
Related Papers
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
|CA A Cancer Journal for Clinicians|2024|22.1k
Global Cancer Statistics, 2002
|CA A Cancer Journal for Clinicians|2005|18.4k
Estimating the world cancer burden: Globocan 2000
|International Journal of Cancer|2001|3.7k
Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis
|The Lancet Global Health|2019|2.4k
Cancer incidence and mortality in China, 2022
|Journal of the National Cancer Center|2024|2k